CIK 0001808805
- Non-accelerated filer
- Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981541723
- Phone
- +1 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2025-06-23 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2022-06-15 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +86,467 | 86,467 |
Page 1 of 1 · 5 trades